- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Catalyst Pharmaceutical Research
Total 1268 results
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMental Disorders | Brain Diseases | Nervous System Diseases | Cognition Disorder
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Terminated
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMental Disorders | Dementia | Alzheimer Disease
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedDiabetes Mellitus | Gastroparesis
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMigraine | Headache | Common Migraine | Classic Migraine
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMigraine | Headache | Common Migraine | Classic Migraine
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophrenia
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedEpilepsy | Epilepsy, Generalized | Seizures | Epilepsies, Partial
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophrenia | Schizoaffective Disorders
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaUnited States
-
Xi'an Xintong Pharmaceutical Research Co.,Ltd.RecruitingChronic Hepatitis bChina
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedUrologic Diseases | Urinary Bladder Diseases | Cystitis | Cystitis, InterstitialUnited States, Canada
-
Vanguard Research GroupOtsuka America PharmaceuticalCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedPain | Osteoarthritis | Joint Pain | Arthralgia | Osteoarthritis, KneeUnited States, Canada
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedPain | Osteoarthritis | Joint Pain | Arthralgia | Osteoarthritis, Knee | Osteoarthritis, HipUnited States, Poland, Canada, Korea, Republic of
-
Pharmaceutical Research Management srlEuropean CommissionTerminatedChronic PainNetherlands, Germany
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Boston Scientific CorporationPharmaceutical Research AssociatesCompletedCoronary Heart DiseaseSpain, Belgium, Latvia, United Kingdom, Germany, France, Ireland, Italy, Poland, Hungary
-
Johnson & Johnson Pharmaceutical Research & Development...WithdrawnNervous System Malformations | Neural Tube Defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedDiabetic NeuropathyUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAllergic RhinitisUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Nutritional and Metabolic DiseasesUnited Kingdom, Germany, Belgium, Poland, India, Finland, Sweden, Netherlands, Russian Federation, Norway, Denmark
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaUnited States, Taiwan, India
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaPoland, United States, Belgium, Taiwan, Spain, Malaysia, Korea, Republic of, Thailand, Slovakia, Croatia
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedRheumatoid ArthritisUnited States, Poland, Germany, Mexico, Brazil, Czech Republic, Argentina
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMalabsorption Syndromes | Cystic Fibrosis | Steatorrhea | Exocrine Pancreatic InsufficiencyUnited States, Canada
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAutistic Disorder | AutismUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaUnited States, Colombia, Ukraine, Argentina, Czech Republic, Slovakia
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedAtopic DermatitisUnited States